comprehensive -WSS

comprehensive

author：entertainment 2025-09-29 21:24:07 - browse：25

Abbott's heart device TriClip on a gradient dark blue background — coverage from STAT — The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. Illustration: STAT; Photo: Courtesy Abbott

An advisory panel to the Food and Drug Administration voted in favor of a new device from Abbott meant to treat patients with tricuspid heart valve disease. All but one of the 14 panelists said the treatment’s benefits outweighed its risks. The FDA tends to follow advisory panel recommendations.

“If we can help symptoms with this at a low cost in terms of risk, I think it makes a lot of sense,” said James Blankenship, a panelist and cardiologist at the University of New Mexico.

The device is called the TriClip, and it addresses a disease called tricuspid regurgitation: a heart condition that causes blood to leak backward through the tricuspid heart valve. The condition impacts 1.6 million people in the United States. Symptoms include fatigue, swelling, and atypical heart rhythms. In severe cases, the condition can lead to heart failure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Obesity drug from Roche shows promise in early study

hotspot

WSS

ALS treatment from Biogen, Ionis fails in study

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Boston Scientific acquires urology company Axonics for $3.7 billion

Male doctors called my cancer incurable. A female doctor showed it wasn't

Nonprofit, backed by Microsoft, to certify AI tools in health care

Does Paxlovid work in people vaccinated against Covid

focus

comprehensive

leisure time

Bright Health sells Medicare Advantage business to Molina

Obesity drug from Roche shows promise in early study

Drug repurposing or repositioning? The language matters

Arena BioWorks launches in Cambridge to speed drug discovery

At least 13 dead in Texas as scorching temps continue

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Alkermes shareholders re

As H5N1 spreads in cows, experts warn against drinking raw milk

Novavax promises a turnaround & Lilly roils the obesity market

As H5N1 spreads in cows, experts warn against drinking raw milk

focus

American taxpayers paid $1.8 trillion in health care costs in 2022

Nonprofit, backed by Microsoft, to certify AI tools in health care

FDA early review: GLP

STAT reporters are Pulitzer Prize finalists for investigative reporting

STAT series 'Denied by AI' wins major journalism prizes

Supreme Court to hear if Covid misinformation is protected speech

hotspot

focus

focus

hotspot